Whittier Trust’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIB
KFS
TFA
ATPW
HIIFS
AIM
Whittier Trust's BIB Position: Q2 2026 in Review
Whittier Trust sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q2 2026, closing a stake of 15 shares — an estimated $1.22K sold.
Whittier Trust first reported a position in BIB in Q3 2024 and held it in 7 quarters. The position peaked at $6.1K in Q4 2025. 5 funds tracked by Wall St. Rank hold BIB as of Q2 2026.
- Whittier Trust reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q2 2026 after selling out during the quarter.
- Whittier Trust sold 15 ProShares Ultra NASDAQ Biotechnology shares in Q2 2026, an estimated $1.22K.
- Whittier Trust first reported a position in ProShares Ultra NASDAQ Biotechnology in Q3 2024 and held it in 7 quarters.
- Whittier Trust's ProShares Ultra NASDAQ Biotechnology position peaked at $6.1K in Q4 2025.
- 5 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2026.
Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.